Join

Compare · ILMN vs MSON

ILMN vs MSON

Side-by-side comparison of Illumina Inc. (ILMN) and MISONIX, Inc. (MSON): market cap, price performance, sector, and recent activity on the wire.

Summary

  • ILMN operates in Health Care, while MSON operates in Capital Goods - the two are in different parts of the market.
  • ILMN is the larger of the two at $19.43B, about 42.0x MSON ($462.5M).
  • ILMN has hit the wire 5 times in the past 4 weeks while MSON has been quiet.
  • ILMN has more recent analyst coverage (25 ratings vs 2 for MSON).
MetricILMNMSON
Company
Illumina Inc.
MISONIX, Inc.
Price
$127.93+2.01%
$26.23+3.72%
Market cap
$19.43B
$462.5M
1M return
+1.37%
-
1Y return
+65.69%
-
Industry
Medical Specialities
Medical Specialities
Exchange
NASDAQ
NASDAQ
IPO
2000
1992
News (4w)
5
0
Recent ratings
25
2
ILMN

Illumina Inc.

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has a collaboration agreement with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer. The company was incorporated in 1998 and is headquartered in San Diego, California.

MSON

MISONIX, Inc.

Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets minimally invasive surgical ultrasonic medical devices in the United States and internationally. The company's products include BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue; SonaStar, a surgical aspirator, which is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system that provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, general surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.

Latest ILMN

Latest MSON